GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Faes Farma SA (XMAD:FAE) » Definitions » Cyclically Adjusted Revenue per Share

Faes Farma (XMAD:FAE) Cyclically Adjusted Revenue per Share : €1.41 (As of Jun. 2023)


View and export this data going back to 2015. Start your Free Trial

What is Faes Farma Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Faes Farma's adjusted revenue per share for the three months ended in Jun. 2023 was €0.338. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €1.41 for the trailing ten years ended in Jun. 2023.

During the past 12 months, Faes Farma's average Cyclically Adjusted Revenue Growth Rate was -100.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Faes Farma was 7.40% per year. The lowest was 7.40% per year. And the median was 7.40% per year.

As of today (2024-06-07), Faes Farma's current stock price is €3.80. Faes Farma's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2023 was €1.41. Faes Farma's Cyclically Adjusted PS Ratio of today is 2.70.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Faes Farma was 4.95. The lowest was 2.04. And the median was 2.96.


Faes Farma Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Faes Farma's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Faes Farma Cyclically Adjusted Revenue per Share Chart

Faes Farma Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.05 1.08 1.19 1.30 -

Faes Farma Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Dec23
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.28 1.30 1.36 1.41 -

Competitive Comparison of Faes Farma's Cyclically Adjusted Revenue per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Faes Farma's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Faes Farma's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Faes Farma's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Faes Farma's Cyclically Adjusted PS Ratio falls into.



Faes Farma Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Faes Farma's adjusted Revenue per Share data for the three months ended in Jun. 2023 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2023 (Change)*Current CPI (Jun. 2023)
=0.338/120.2784*120.2784
=0.338

Current CPI (Jun. 2023) = 120.2784.

Faes Farma Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201309 0.019 100.597 0.023
201312 0.748 101.306 0.888
201403 0.000 100.139 0.000
201406 0.021 101.081 0.025
201409 0.001 100.441 0.001
201412 0.774 100.251 0.929
201503 0.000 99.474 0.000
201506 0.004 101.138 0.005
201509 0.018 99.559 0.022
201512 0.783 100.268 0.939
201603 0.000 98.638 0.000
201606 0.004 100.333 0.005
201609 0.646 99.737 0.779
201612 0.225 101.842 0.266
201703 0.229 100.896 0.273
201706 0.246 101.848 0.291
201709 0.272 101.524 0.322
201712 0.283 102.975 0.331
201803 0.011 102.122 0.013
201806 0.589 104.165 0.680
201809 -0.557 103.818 -0.645
201812 1.132 104.193 1.307
201903 0.016 103.488 0.019
201906 0.608 104.612 0.699
201909 0.371 103.905 0.429
201912 0.245 105.015 0.281
202003 0.420 103.469 0.488
202006 0.271 104.254 0.313
202009 0.394 103.521 0.458
202012 0.220 104.456 0.253
202103 0.345 104.857 0.396
202106 0.287 107.102 0.322
202109 0.423 107.669 0.473
202112 0.255 111.298 0.276
202203 0.393 115.153 0.410
202206 0.333 118.044 0.339
202209 0.381 117.221 0.391
202212 0.273 117.650 0.279
202303 0.409 118.948 0.414
202306 0.338 120.278 0.338

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Faes Farma  (XMAD:FAE) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Faes Farma's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=3.80/1.41
=2.70

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Faes Farma was 4.95. The lowest was 2.04. And the median was 2.96.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Faes Farma Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Faes Farma's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Faes Farma (XMAD:FAE) Business Description

Industry
Traded in Other Exchanges
Address
Maximo Aguirre, 14, Leioa, Vizcaya, ESP, 48940
Faes Farma SA is a pharmaceutical company that specializes in the research, production, distribution, and sale of prescription and generic drugs, over-the-counter medicines, food supplements and personal care treatments, as well as raw materials for the pharmaceutical use. The company develops new drugs for the treatment of allergy, venous insufficiency, and irritable bowel syndrome. It also provides animal nutrition products. Faes Farma exports its products to more than 60 countries and has operations in Spain, Portugal, Chile, and Mexico, among others.

Faes Farma (XMAD:FAE) Headlines

No Headlines